Expert Video - Why are Black American lung cancer patients less likely to participate in clinical trials?
Janine Harewood, MD, discusses Black Americans' medical distrust as a barrier to lung cancer clinical trial participation. Many Black Americans are less likely to participate in clinical trials for lung cancer due to social and economic factors that affect Black healthcare, such as low access and a lack of lung cancer treatment options and low Black American awareness of lung cancer clinical trials.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
This educational activity has been developed by
A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.